News

MRNA Q2 Deep Dive: Revenue Beat Overshadowed by Lower Guidance and Cost Cuts

Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...

The future of cancer treatment is ‘personalized’ mRNA vaccines. Experts fear RFK research cuts will jeopardize that

Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...

HHS phases out mRNA vaccine trials for COVID-19, bird flu

The Trump administration on Tuesday eliminated 22 mRNA vaccine development projects for COVID-19 and bird flu, a stark shift ...

Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
VTDigger12h

How federal cuts to mRNA vaccine development will affect Vermont

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

Jay Bhattacharya: Why the NIH is pivoting away from mRNA vaccines

Jay Bhattacharya is director of the National Institutes of Health.

Vaccinating young children against Covid-19 may be more challenging this respiratory virus season

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
STAT1d

NIH director: mRNA vaccine contracts were canceled because public lacks trust in technology

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...